Bide Pharmaceuticals (688073.SH) terminates additional acquisitions

Zhitongcaijing · 5d ago

Zhitong Finance App News, Bide Pharmaceutical (688073.SH) announced that on April 14, 2025, the company held the 19th meeting of the 2nd board of directors and the 15th meeting of the 2nd board of supervisors to review and pass the “Proposal on Termination of Issuance of Shares to Purchase Assets and Raise Supporting Funds”, agreeing that the company would terminate the issuance of shares to purchase assets and raise supporting capital, and authorized the company's management to handle matters related to this termination.